FindTrial
Sign In

comparision of Dexmedetomidine and Thiopental with ?Dexmedetomidine and Ketamin on hemodynamic response ?and duration of seizure in patients candidated for ECT

comparision of Dexmedetomidine and Thiopental with ?Dexmedetomidine and Ketamin on hemodynamic response ?and duration of seizure in patients candidated for ECT

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20141209020258N81
Enrollment
104
Registered
2018-06-12
Start date
2017-11-26
Completion date
Unknown
Last updated
2018-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Electroconvulsive therapy.

Interventions

Intervention 1: Intervention group: We treat patients 0/5 micro gram in kilogram Dexmedetomidine and 3-5 micro gram in kilogram Tiopantal in first group. Intervention 2: Intervention group: We treat p

Sponsors

Arak University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: no addiction

Exclusion criteria

Exclusion criteria: Seizures are less than 25 seconds or they may have arrhythmias or hemodynamic threats during the ECT

Design outcomes

Primary

MeasureTime frame
Duration of recovery. Timepoint: fisrt and end of recovery. Method of measurement: minute.;Duration of seizure after entering recovery. Timepoint: start and end of seizure. Method of measurement: minute.;Blood pressure. Timepoint: Before and after ECT and recovery. Method of measurement: Barometer.;Heart rate. Timepoint: Before and after ECT and recovery. Method of measurement: Beats in minutes.;Duration of seizure. Timepoint: Start and end of seizure. Method of measurement: Minute.—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Alireza Kamali

Arak University of Medical Sciences

alikamaliir@yahoo.com+98 86 3222 2003

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026